3SBIO (01530.HK) -0.680 (-1.907%) Short selling $243.85M; Ratio 12.530% 's 1H25 revenue fell 0.8% YoY to RMB4.356 billion, while net profit attributable to shareholders increased by 24.6% YoY to RMB1.358 billion, according to CICC's research report. Adjusted net profit grew by 2.1% YoY to RMB1.136 billion, in line with market consensus.Considering the revenue recognition from business development achievements, the broker raised its 2025/ 2026 net profit forecasts by 186.5%/ 138.3% to RMB6.249 billion/ RMB5.664 billion, with rating kept at Outperform. Related NewsSoochow Securities Lists Top 10 Net Buys, Net Sells by Southbound Funds in HK Mkt Last Wk (Table)Based on market recognition of the Company's innovative product pipeline, CICC lifted its target price by 39.9% to $36.5, equivalent to its projected 2025/ 2026 PE ratios of 13x/ 14.2x, respectively. (HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-09-08 16:25.)